Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 13Obesity 6Weight Loss 5Overweight 3Menstruation Disturbances 2Intermittent Fasting 2Insulin Resistance 2Tumor Surgery 1Sarcopenia 1Postoperative Complications 1Obesity, Abdominal 1Muscle Weakness 1Motor Activity 1Moderately Overweight Individuals 1Metabolic Syndrome 1Metabolic Diseases 1Infertility 1Glucocorticoid Receptor Deficiency 1Fasting 1Esophageal Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1Breast Cancer Female 1Body Weight 1

Interventions

Metformin 30Exercise 8Pioglitazone 7Inositol 6Insulin 5Acupuncture Therapy 4High-Intensity Interval Training 3Ethinyl Estradiol 3salicylsalicylic acid 2drospirenone and ethinyl estradiol combination 2Water 2Tablets 2Surveys and Questionnaires 2Sugars 2Resistance Training 2Preoperative Exercise 2Observation 2Folic Acid 2Diet Therapy 2Cyproterone Acetate 2Cholecalciferol 2Caloric Restriction 2Biguanides 2ziprasidone 1maltodextrin 1lime 1licogliflozin 1exendin (9-39) 1drospirenone 1cinnulin PF 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Insulin Resistance × Caloric Restriction × Clear all
NCT07380841 2026-02-02

PCOS-COMBO (9)

Islamabad Medical and Dental College

Phase NA Completed
192 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Weight Loss, Metabolic Syndrome

NCT01482286 2022-03-15

PULSE

Pennington Biomedical Research Center

Phase 3 Terminated
32 enrolled 10 charts

Body Weight, Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡